Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients

NCT00187265 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-02-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the feasibility of permanent biventricular pacing using three ventricular leads, and its efficacy in terms of inter and intra-ventricular resynchronization, in patients with congestive heart failure and a non-functional atrium (chronic AF).

Conditions

Interventions

DEVICE

Cardiac Resynchronization Therapy

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Jean-Claude Daubert · CHU Pontchaillou Rennes France

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Completion
2005-10-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00187265 on ClinicalTrials.gov